Kumquat’s mission is to develop innovative therapies to bring about sustainable and life-changing benefits to cancer patients.
Employees: 11-50
Investors 2
| Date | Name | Website |
| - | OrbiMed | orbimed.co... |
| - | EcoR1 Capi... | ecor1cap.c... |
Mentions in press and media 2
| Date | Title | Description |
| 29.07.2021 | Eli Lilly hands Kumquat Biosciences $70M to kick off cancer drug R&D alliance | Eil Lilly is in the hunt for new immuno-oncology drugs and it’s paying Kumquat Biosciences $70 million to find them. The sum, comprised of cash and an equity investment, is an upfront payment to begin a multi-year drug discovery and develop... |
| - | Eli Lilly hands Kumquat Biosciences $70M to kick off cancer drug R&D alliance | Eil Lilly is in the hunt for new immuno-oncology drugs and it’s paying Kumquat Biosciences $70 million to find them. The sum, comprised of cash and an equity investment, is an upfront payment to begin a multi-year drug discovery and develop... |